By Elizabeth Fairley, COO/CDO, Talking Medicines
In the age of AI, it’s easy to get swept up in the hype. But for healthcare and Life Sciences, generic AI models are not enough. At Talking Medicines, we believe Life Sciences need something purpose-built. That means Advanced Data Science and AI grounded in deep domain knowledge, regulatory awareness, and real-world healthcare data.
During a recent LinkedIn Live session, I was joined by Roma English Owen, our AVP Data Intelligence, to unpack how Talking Medicines approaches AI differently. We also discussed why that difference matters so much for Pharma and Healthcare Marketing Agencies.
The Problem: Untapped Intelligence in HCP and Patient Conversations
Pharmaceutical companies and their Healthcare Advertising Agencies are facing a growing challenge. While vast volumes of unstructured conversational data are being generated every day, from HCP discussions to Patient feedback, surfacing relevant, regulatory-aligned intelligence from this data is still out of reach for many.
That is where we come in.
At Talking Medicines, we structure this rich unstructured data and transform it into actionable insights. Our customers, which include Strategists across Healthcare Agencies and Pharma companies, use this intelligence to make more informed decisions that resonate with both Patients and Healthcare Professionals.
Our Approach: AI as a Discipline, Not a Trend
We do not see AI as a tool to simply plug in. We see it as a deep, evolving discipline. Some in the industry remain cautious and are concerned about opaque black-box models or data privacy risks. Others are moving quickly, using AI to accelerate discovery, improve targeting, and boost productivity.
We believe both instincts are valid. That is why we have built our AI with Life Sciences at its core.
Sector-specific AI is no longer a luxury. It is a necessity.
Just like cars evolved from crank handles to autonomous driving systems, AI has progressed from basic rule-based logic to intelligent systems that learn, adapt, and make decisions in real time. But that evolution only works if you train and govern AI with the right data, the right context, and the right ethical guardrails.
Why This Matters for Healthcare Agencies
In a landscape where strategy teams are under pressure to demonstrate real impact, we help bridge the gap between raw health conversations and strategic action. Our Advanced Data Science and AI solution, DrugVoice is built to deliver compliance-aware, medically relevant, and insight-rich outputs from HCP and Patient voices.
Because when it comes to making smart decisions, instinct alone is no longer enough. You need intelligence that is as sophisticated and as specific as the audiences you are trying to reach. Get in touch to learn more – We’d love to hear from you.
